Official Title

A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects
  • Phase

    Phase 4
  • Lead Sponsor

    3M
  • Study Type

    Interventional
  • Study Participants

    33
Evaluate the effect of two hand antiseptic products on hand skin conditions of healthy volunteers.
Study Started
Mar 31
2008
Primary Completion
Apr 30
2008
Study Completion
Jul 31
2008
Results Posted
Jun 17
2009
Estimate
Last Update
Jan 26
2012
Estimate

Drug Avagard

Topical solution, 6 mL, 6 applications/day for 14 days.

Drug Purell Surgical Scrub

Topical solution, 4 mL, 6 applications/day for 14 days.

  • Other names: Purell Surgical Scrub with Moisturizers

Avagard Experimental

3M Avagard Surgical and healthcare Personnel Hand Antiseptic with Moisturizers

Purell Active Comparator

Purell Surgical Scrub with Moisturizers

Criteria

Inclusion Criteria:

Female age 25 - 55
Subject agrees not to use any hand wash products on their hands other than what has been provided in the study.
Subject agrees not to use any moisturizers or any skin products on their hands during the study
Subject agrees to use gloves to protect hands from activities such as dish washing
Subject is willing to sign the Informed Consent and HIPAA
Subject agrees to comply with the study requirement

Exclusion Criteria:

Subject has a history of psoriasis, active dermatitis, skin reactions, cracked, irritated, broken skin, skin infection on their hands
Subject has scaly skin on hands based on Visual Scoring Scale at Day 1
Subject has a sensitivity or history of skin reactions to any study materials (eg, alcohol, chlorhexidine gluconate or zinc pyrithone or latex in the gloves)
Subject has been using moisturizing products or any products on their arms and hands within 5 days prior to participation in the study
Subject is pregnant
Study coordinator believes the subject is unsuitable for inclusion in the study

Summary

Purell First Followed by Avagard

Avagard First Followed by Purell

All Events

Event Type Organ System Event Term

Change From Baseline in Skin Health, Visual Skin Score (VSS) at 14 Days

Observe VSS score at 14 days, and graded change of skin health from baseline using scale of 0 (normal) - 5 (very scaly).

Purell First Followed by Avagard

0.1
units on a scale (Mean)
Standard Deviation: 1.11

Avagard First Followed by Purell

0.4
units on a scale (Mean)
Standard Deviation: 1.53

Total

33
Participants

Age, Categorical

Sex: Female, Male

First Intervention

Purell First Followed by Avagard

Avagard First Followed by Purell

Wash-out

Purell First Followed by Avagard

Avagard First Followed by Purell

Second Intervention

Purell First Followed by Avagard

Avagard First Followed by Purell

Drop/Withdrawal Reasons

Avagard First Followed by Purell